Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Whelan

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Cancer Nursing|October 30, 2015
Mapping Adolescent Cancer Services: How Do Young People, Their Families, and Staff Describe Specialized Cancer Care in England?Cecilia Vindrola-Padros, Rachel M Taylor, Sarah Lea, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2022
Survival after high-dose chemotherapy for refractory and recurrent Ewing sarcomaRachael Windsor, Anthony Hamilton, Anne McTiernan, et al.
BMJ Open|March 5, 2022
Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trialAudinga-Dea Hazewinkel, Carlo Lancia, Jakob Anninga, et al.
BMC Cancer|January 16, 2014
Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?Anna Maria Frezza, Tim Beale, Jamshed Bomanji, et al.
Sarcoma|January 22, 2011
UK Guidelines for the Management of Bone SarcomasRobert Grimer, Nick Athanasou, Craig Gerrand, et al.
Clinical Sarcoma Research|May 6, 2016
UK guidelines for the management of bone sarcomasCraig Gerrand, Nick Athanasou, Bernadette Brennan, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 31, 2011
How frequently do young people with potential cancer symptoms present in primary care?Lorna A Fern, Christine Campbell, Tim Ob Eden, et al.
BMJ Open|June 2, 2019
Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcomaCarlo Lancia, Jakob Anninga, Cristian Spitoni, et al.
Pediatric Blood & Cancer|November 12, 2021
Current approaches to management of bone sarcoma in adolescent and young adult patientsKatrina M Ingley, Alessandra Maleddu, Franel Le Grange, et al.
Pediatric Blood & Cancer|March 31, 2006
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trialChristine Juergens, Claire Weston, Ian Lewis, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Cancer Nursing|October 30, 2015
Mapping Adolescent Cancer Services: How Do Young People, Their Families, and Staff Describe Specialized Cancer Care in England?Cecilia Vindrola-Padros, Rachel M Taylor, Sarah Lea, et al.
European Journal of Cancer (Oxford, England : 1990)|May 31, 2022
Survival after high-dose chemotherapy for refractory and recurrent Ewing sarcomaRachael Windsor, Anthony Hamilton, Anne McTiernan, et al.
BMJ Open|March 5, 2022
Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trialAudinga-Dea Hazewinkel, Carlo Lancia, Jakob Anninga, et al.
BMC Cancer|January 16, 2014
Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?Anna Maria Frezza, Tim Beale, Jamshed Bomanji, et al.
Sarcoma|January 22, 2011
UK Guidelines for the Management of Bone SarcomasRobert Grimer, Nick Athanasou, Craig Gerrand, et al.
Clinical Sarcoma Research|May 6, 2016
UK guidelines for the management of bone sarcomasCraig Gerrand, Nick Athanasou, Bernadette Brennan, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 31, 2011
How frequently do young people with potential cancer symptoms present in primary care?Lorna A Fern, Christine Campbell, Tim Ob Eden, et al.
BMJ Open|June 2, 2019
Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcomaCarlo Lancia, Jakob Anninga, Cristian Spitoni, et al.
Pediatric Blood & Cancer|November 12, 2021
Current approaches to management of bone sarcoma in adolescent and young adult patientsKatrina M Ingley, Alessandra Maleddu, Franel Le Grange, et al.
Pediatric Blood & Cancer|March 31, 2006
Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trialChristine Juergens, Claire Weston, Ian Lewis, et al.
Pageof 9